Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Lifetime Depression, Other Mental Illness, and Smoking Cessation.

Huffman AL, Bromberg JE, Augustson EM.

Am J Health Behav. 2018 Jul 1;42(4):90-101. doi: 10.5993/AJHB.42.4.9.

PMID:
29973314
2.

Flow cytometry shows added value in diagnosing lymphoma in brain biopsies.

van der Meulen M, Bromberg JEC, Lam KH, Dammers R, Langerak AW, Doorduijn JK, Kros JM, van den Bent MJ, van der Velden VHJ.

Cytometry B Clin Cytom. 2018 May 10. doi: 10.1002/cyto.b.21641. [Epub ahead of print]

PMID:
29747221
3.

Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes.

Grasedieck S, Mulaw M, Sperb N, Wessinger K, Rouhi A, Bommer M, Bromberg JEC, Otto M, Tumani H, von Arnim CAF, Mertens D, Kuchenbauer F.

Neuropathol Appl Neurobiol. 2018 Apr 21. doi: 10.1111/nan.12491. [Epub ahead of print] No abstract available.

PMID:
29679382
4.

Efficacy of intrathecal chemotherapy in patients with central nervous system involvement of hematological malignancies: a retrospective analysis.

Dara A, Mook BB, Doorduijn JK, van den Bent MJ, Dinmohamed AG, Bromberg JEC.

J Neurooncol. 2018 Aug;139(1):117-123. doi: 10.1007/s11060-018-2849-x. Epub 2018 Apr 9.

PMID:
29633110
5.

Primary CNS lymphoma in HIV infection.

Brandsma D, Bromberg JEC.

Handb Clin Neurol. 2018;152:177-186. doi: 10.1016/B978-0-444-63849-6.00014-1.

PMID:
29604975
6.

Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015.

van der Meulen M, Dinmohamed AG, Visser O, Doorduijn JK, Bromberg JEC.

Leukemia. 2017 Aug;31(8):1822-1825. doi: 10.1038/leu.2017.128. Epub 2017 Apr 28. No abstract available.

PMID:
28450731
7.

Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma.

Nijland M, Jansen A, Doorduijn JK, Enting RH, Bromberg JEC, Kluin-Nelemans HC.

Leuk Lymphoma. 2017 Sep;58(9):1-6. doi: 10.1080/10428194.2017.1285026. Epub 2017 Feb 6.

PMID:
28278731
8.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJ, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.

Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.

9.

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Reijneveld JC, Taphoorn MJ, Coens C, Bromberg JE, Mason WP, Hoang-Xuan K, Ryan G, Hassel MB, Enting RH, Brandes AA, Wick A, Chinot O, Reni M, Kantor G, Thiessen B, Klein M, Verger E, Borchers C, Hau P, Back M, Smits A, Golfinopoulos V, Gorlia T, Bottomley A, Stupp R, Baumert BG.

Lancet Oncol. 2016 Nov;17(11):1533-1542. doi: 10.1016/S1470-2045(16)30305-9. Epub 2016 Sep 27.

PMID:
27686943
10.

Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.

Doorduijn JK, van Imhoff GW, van der Holt B, Schouten HC, Schaafsma MR, MacKenzie MA, Baars JW, Kersten MJ, Lugtenburg PJ, van den Bent MJ, Enting RH, Spoelstra FM, Poortmans P, Bromberg JEC.

Hematol Oncol. 2017 Dec;35(4):497-503. doi: 10.1002/hon.2342. Epub 2016 Aug 17.

PMID:
27530779
11.

To be in pain (or not): a computer enables outpatients to inform their physician.

Oldenmenger WH, Witkamp FE, Bromberg JE, Jongen JL, Lieverse PJ, Huygen FJ, Baan MA, van Zuylen L, van der Rijt CC.

Ann Oncol. 2016 Sep;27(9):1776-81. doi: 10.1093/annonc/mdw250. Epub 2016 Jul 20.

PMID:
27443633
12.

Low-grade and anaplastic oligodendroglioma.

Van Den Bent MJ, Bromberg JE, Buckner J.

Handb Clin Neurol. 2016;134:361-80. doi: 10.1016/B978-0-12-802997-8.00022-0. Review.

PMID:
26948366
13.

Text to Quit China: An mHealth Smoking Cessation Trial.

Augustson E, Engelgau MM, Zhang S, Cai Y, Cher W, Li R, Jiang Y, Lynch K, Bromberg JE.

Am J Health Promot. 2017 May;31(3):217-225. doi: 10.4278/ajhp.140812-QUAN-399. Epub 2016 Jan 5.

14.

Neuro-oncology: The many challenges of treating elderly glioblastoma patients.

van den Bent MJ, Bromberg JE.

Nat Rev Neurol. 2015 Jul;11(7):374-5. doi: 10.1038/nrneurol.2015.82. Epub 2015 May 19. No abstract available.

PMID:
25986504
15.

Chemotherapy in glioma.

Taal W, Bromberg JE, van den Bent MJ.

CNS Oncol. 2015;4(3):179-92. doi: 10.2217/cns.15.2. Epub 2015 Apr 23. Review.

PMID:
25906059
16.

The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial.

Dirven L, van den Bent MJ, Bottomley A, van der Meer N, van der Holt B, Vos MJ, Walenkamp AM, Beerepoot LV, Hanse MC, Reijneveld JC, Otten A, de Vos FY, Smits M, Bromberg JE, Taal W, Taphoorn MJ; Dutch Neuro-Oncology Group (LWNO).

Eur J Cancer. 2015 Jul;51(10):1321-30. doi: 10.1016/j.ejca.2015.03.025. Epub 2015 Apr 17.

PMID:
25899986
17.

Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Toelle SP, Poretti A, Weber P, Seute T, Bromberg JE, Scheer I, Boltshauser E.

Cerebellum. 2015 Dec;14(6):642-9. doi: 10.1007/s12311-015-0658-8.

PMID:
25728839
18.

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.

Taal W, van der Rijt CC, Dinjens WN, Sillevis Smitt PA, Wertenbroek AA, Bromberg JE, van Heuvel I, Kros JM, van den Bent MJ.

J Neurooncol. 2015 Jan;121(2):365-72. doi: 10.1007/s11060-014-1641-9. Epub 2014 Oct 26.

PMID:
25344884
19.

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.

Koekkoek JA, Kerkhof M, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Bromberg JE, van den Bent MJ, Reijneveld JC, Taphoorn MJ.

BMC Neurol. 2014 Aug 15;14:157. doi: 10.1186/s12883-014-0157-4.

20.

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Taal W, Oosterkamp HM, Walenkamp AM, Dubbink HJ, Beerepoot LV, Hanse MC, Buter J, Honkoop AH, Boerman D, de Vos FY, Dinjens WN, Enting RH, Taphoorn MJ, van den Berkmortel FW, Jansen RL, Brandsma D, Bromberg JE, van Heuvel I, Vernhout RM, van der Holt B, van den Bent MJ.

Lancet Oncol. 2014 Aug;15(9):943-53. doi: 10.1016/S1470-2045(14)70314-6. Epub 2014 Jul 15.

PMID:
25035291
21.

A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

de Jongste AH, van Gelder T, Bromberg JE, de Graaf MT, Gratama JW, Schreurs MW, Hooijkaas H, Sillevis Smitt PA.

Neuro Oncol. 2015 Jan;17(1):145-50. doi: 10.1093/neuonc/nou126. Epub 2014 Jul 3.

22.

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

Wilson WH, Bromberg JE, Stetler-Stevenson M, Steinberg SM, Martin-Martin L, Muñiz C, Sancho JM, Caballero MD, Davidis MA, Brooimans RA, Sanchez-Gonzalez B, Salar A, González-Barca E, Ribera JM, Shovlin M, Filie A, Dunleavy K, Mehrling T, Spina M, Orfao A.

Haematologica. 2014 Jul;99(7):1228-35. doi: 10.3324/haematol.2013.101741. Epub 2014 Apr 11.

23.

Food insecurity, cigarette smoking, and acculturation among Latinos: data from NHANES 1999-2008.

Iglesias-Rios L, Bromberg JE, Moser RP, Augustson EM.

J Immigr Minor Health. 2015 Apr;17(2):349-57. doi: 10.1007/s10903-013-9957-7.

24.

Current treatment of low grade gliomas.

van den Bent MJ, Snijders TJ, Bromberg JE.

Memo. 2012 Sep;5(3):223-227. Epub 2012 Jun 5.

25.

Use of TransFix™ cerebrospinal fluid storage tubes prevents cellular loss and enhances flow cytometric detection of malignant hematological cells after 18 hours of storage.

de Jongste AH, Kraan J, van den Broek PD, Brooimans RA, Bromberg JE, van Montfort KA, Smitt PA, Gratama JW.

Cytometry B Clin Cytom. 2014 Jul;86(4):272-9. doi: 10.1002/cyto.b.21097. Epub 2013 May 14.

26.

Primary intracranial germ-cell tumors in adults: a practical review.

Bromberg JE, Baumert BG, de Vos F, Gijtenbeek JM, Kurt E, Westermann AM, Wesseling P.

J Neurooncol. 2013 Jun;113(2):175-83. doi: 10.1007/s11060-013-1114-6. Epub 2013 Mar 23. Review.

PMID:
23526409
27.

Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma.

Missotten T, Tielemans D, Bromberg JE, van Hagen PM, van Lochem EG, van Dongen JJ, Baarsma GS, Langerak AW.

Ophthalmology. 2013 May;120(5):991-6. doi: 10.1016/j.ophtha.2012.11.007. Epub 2013 Feb 4.

PMID:
23380473
28.

Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project.

Bromberg JE, Doorduijn JK, Illerhaus G, Jahnke K, Korfel A, Fischer L, Fritsch K, Kuittinen O, Issa S, van Montfort C, van den Bent MJ.

Haematologica. 2013 May;98(5):808-13. doi: 10.3324/haematol.2012.070839. Epub 2012 Nov 9.

29.

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

Taal W, Segers-van Rijn JM, Kros JM, van Heuvel I, van der Rijt CC, Bromberg JE, Sillevis Smitt PA, van den Bent MJ.

J Neurooncol. 2012 May;108(1):195-200. doi: 10.1007/s11060-012-0832-5. Epub 2012 Mar 7.

30.

Anaplastic oligodendroglial tumors.

van den Bent MJ, Bromberg JE.

Handb Clin Neurol. 2012;105:467-84. doi: 10.1016/B978-0-444-53502-3.00003-3. Review. No abstract available.

PMID:
22230513
31.

Portrayal of smokeless tobacco in YouTube videos.

Bromberg JE, Augustson EM, Backinger CL.

Nicotine Tob Res. 2012 Apr;14(4):455-62. doi: 10.1093/ntr/ntr235. Epub 2011 Nov 11.

32.

Acute painful lumbosacral paresthesia after intrathecal rituximab.

Bromberg JE, Doorduijn JK, Baars JW, van Imhoff GW, Enting R, van den Bent MJ.

J Neurol. 2012 Mar;259(3):559-61. doi: 10.1007/s00415-011-6190-y. Epub 2011 Aug 10. No abstract available.

33.

Higher doses of opioids in patients who need palliative sedation prior to death: cause or consequence?

Oosten AW, Oldenmenger WH, van Zuylen C, Schmitz PI, Bannink M, Lieverse PJ, Bromberg JE, van der Rijt CC.

Eur J Cancer. 2011 Oct;47(15):2341-6. doi: 10.1016/j.ejca.2011.06.057. Epub 2011 Jul 26.

34.

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.

Stupp R, Tosoni A, Bromberg JE, Hau P, Campone M, Gijtenbeek J, Frenay M, Breimer L, Wiesinger H, Allgeier A, van den Bent MJ, Bogdahn U, van der Graaf W, Yun HJ, Gorlia T, Lacombe D, Brandes AA.

Ann Oncol. 2011 Sep;22(9):2144-9. doi: 10.1093/annonc/mdq729. Epub 2011 Feb 14.

35.

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.

Taal W, Dubbink HJ, Zonnenberg CB, Zonnenberg BA, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Kros JM, Kouwenhoven MC, van Marion R, van Heuvel I, van der Holt B, Bromberg JE, Sillevis Smitt PA, Dinjens WN, van den Bent MJ; Dutch Society for Neuro-Oncology.

Neuro Oncol. 2011 Feb;13(2):235-41. doi: 10.1093/neuonc/noq177. Epub 2010 Dec 21.

36.

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.

Schuurmans M, Bromberg JE, Doorduijn J, Poortmans P, Taphoorn MJ, Seute T, Enting R, van Imhoff G, van Norden Y, van den Bent MJ.

Br J Haematol. 2010 Oct;151(2):179-84. doi: 10.1111/j.1365-2141.2010.08328.x. Epub 2010 Aug 25.

PMID:
20738305
37.

Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes.

van Broekhoven F, de Graaf MT, Bromberg JE, Hooijkaas H, van den Bent MJ, de Beukelaar JW, Khan NA, Gratama JW, van der Geest JN, Frens M, Benner R, Sillevis Smitt PA.

J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1341-4. doi: 10.1136/jnnp.2009.177865. Epub 2010 Jul 28.

PMID:
20667866
38.

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.

Dubbink HJ, Taal W, van Marion R, Kros JM, van Heuvel I, Bromberg JE, Zonnenberg BA, Zonnenberg CB, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Smitt PA, Dinjens WN, van den Bent MJ.

Neurology. 2009 Nov 24;73(21):1792-5. doi: 10.1212/WNL.0b013e3181c34ace.

PMID:
19933982
39.

No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.

de Beukelaar JW, Milikan JC, Verjans GM, de Graaf MT, van Norden Y, Lamers CH, van den Bent MJ, Bromberg JE, Hulsenboom E, Sintnicolaas K, Gratama JW, Sillevis Smitt PA.

J Neurol. 2009 Feb;256(2):279-82. doi: 10.1007/s00415-009-0051-y. Epub 2009 Feb 27. No abstract available.

PMID:
19252764
40.

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ.

Neuro Oncol. 2009 Dec;11(6):737-46. doi: 10.1215/15228517-2009-011.

41.

Oligodendrogliomas: molecular biology and treatment.

Bromberg JE, van den Bent MJ.

Oncologist. 2009 Feb;14(2):155-63. doi: 10.1634/theoncologist.2008-0248. Epub 2009 Jan 31. Review.

42.

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.

Taal W, Brandsma D, de Bruin HG, Bromberg JE, Swaak-Kragten AT, Smitt PA, van Es CA, van den Bent MJ.

Cancer. 2008 Jul 15;113(2):405-10. doi: 10.1002/cncr.23562.

43.

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.

Doolittle ND, Abrey LE, Shenkier TN, Tali S, Bromberg JE, Neuwelt EA, Soussain C, Jahnke K, Johnston P, Illerhaus G, Schiff D, Batchelor T, Montoto S, Kraemer DF, Zucca E.

Blood. 2008 Feb 1;111(3):1085-93. Epub 2007 Oct 25.

44.

CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.

Bromberg JE, Breems DA, Kraan J, Bikker G, van der Holt B, Smitt PS, van den Bent MJ, van't Veer M, Gratama JW.

Neurology. 2007 May 15;68(20):1674-9.

PMID:
17502548
45.

[Three patients with a paraneoplastic neurological syndrome: the significance of paraneoplastic antibodies].

Smitt PA, Polman SK, de Beukelaar JW, Enting RH, van den Bent MJ, Bromberg JE, Kros JM, Hooijkaas H.

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):874-80. Dutch.

PMID:
17472120
46.

Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines.

Correa DD, Maron L, Harder H, Klein M, Armstrong CL, Calabrese P, Bromberg JE, Abrey LE, Batchelor TT, Schiff D.

Ann Oncol. 2007 Jul;18(7):1145-51. Epub 2007 Feb 6. Review.

PMID:
17284616
47.

Corticosteroid use and risk of aneurysmal subarachnoid haemorrhage.

Ruigrok YM, Dekkers PJ, Bromberg JE, Algra A, Rinkel GJ.

J Neurol. 2006 Apr;253(4):496-9. Epub 2005 Nov 24.

PMID:
16307204
48.

Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas.

Reijneveld JC, van der Grond J, Ramos LM, Bromberg JE, Taphoorn MJ.

Neuroradiology. 2005 Dec;47(12):887-91. Epub 2005 Aug 20.

PMID:
16133483
49.

[Temozolomide in patients with a glioblastoma multiforme: new developments].

Bromberg JE, Postma TJ.

Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1376-8. Dutch.

PMID:
15997689
50.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R.

N Engl J Med. 2005 Mar 10;352(10):997-1003.

Supplemental Content

Loading ...
Support Center